Association of biochemical markers with time of onset and severity of hypertensive disorder of pregnancy

Aditi Jaiswal; Nupur Hooja; Pooja Sharma; Monika; Krupa Verma; Babita Panwar

doi:10.18203/2320-1770.ijrcog20232276

Authors

Aditi Jaiswal Department of Obstetrics and Gynecology, S. M. S. Medical College, Jaipur, Rajasthan, India
Nupur Hooja Department of Obstetrics and Gynecology, S. M. S. Medical College, Jaipur, Rajasthan, India
Pooja Sharma Department of Obstetrics and Gynecology, S. M. S. Medical College, Jaipur, Rajasthan, India
Monika Department of Obstetrics and Gynecology, S. M. S. Medical College, Jaipur, Rajasthan, India
Krupa Verma Department of Obstetrics and Gynecology, S. M. S. Medical College, Jaipur, Rajasthan, India
Babita Panwar Department of Obstetrics and Gynecology, S. M. S. Medical College, Jaipur, Rajasthan, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20232276

Keywords:

Hypertensive disorders of pregnancy, hs- CRP, Inflammatory markers, Interleukin 6

Abstract

Background: Hypertensive disorders of pregnancy (HDP) are a common cause of morbidity and mortality. Inflammation is considered as one of the etiologic factors along with a complex interplay of multiple genetic, nutritional and other environmental agents. This study was undertaken to find association of biochemical markers with severity and time of onset of HDP.

Methods: Institutional review board and ethics committee approval was taken prior to the study. History and examination was done. Blood pressure was recorded at each antenatal visit. Blood samples were taken for the study of biochemical markers-hsCRP and interleukin 6 levels. Data was analyzed. P value <0.05 was taken as significant.

Results: Of the 80 women, 27.5% had early onset HDP. 72.5% had severe HDP. Inflammatory indices were altered as compared to the range of normal pregnant women. Mean IL-6 and hsCRP levels were found to be raised but no statistically significant association was observed between IL-6 levels or hs-CRP levels and time of onset of HDP (p value = 1 and 0.5859 respectively and severity of onset of HDP (p value = 0.197 and 0.453 respectively).

Conclusions: Biochemical indices, IL-6 and hs-CRP levels were elevated in women with HDP, indicative of increased inflammation.

Metrics

Metrics Loading ...

References

Mol BW, Roberts CT, Thangaratinam S, Magee LA, De Groot CJ, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387(10022):999-1011.

Mehta B, Kumar V, Chawla S, Sachdeva S, Mahopatra D. Hypertension in pregnancy: a community-based study. Ind J Commu Medi:Pub Ind Associa Prevent Soci Medi. 2015;40(4):273.

Mtali YS, Lyimo MA, Luzzatto L, Massawe SN. Hypertensive disorders of pregnancy are associated with an inflammatory state: evidence from hematological findings and cytokine levels. BMC Preg Childb. 2019;19(1):1-9.

Kong D, Wang H, Liu Y, Li H, Wang H, Zhu P. Correlation between the expression of inflammatory cytokines IL-6, TNF-α and hs-CRP and unfavorable fetal outcomes in patients with pregnancy-induced hypertension. Experim Therap Med. 2018;16(3):1982-6.

Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol-H Circul Physio. 2008;294(2):H541-50.

Luppi P, DeLoia JA. Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clinical immunology. 2006;118(2-3):268-75.

Küçük M, Sezer SD, Yenisey Ç, Yüksel H, Odabaşı AR. Comparison of interleukin-6 levels in maternal and umbilical cord blood in early-and late-onset preeclampsia. Gyn Endocrinol. 2012;28(8):640-3.

Xiao JP, Yin YX, Gao YF, Lau S, Shen F, Zhao M, Chen Q. The increased maternal serum levels of IL-6 are associated with the severity and onset of preeclampsia. Cytokine. 2012;60(3):856-60.

Gencheva DG, Nikolov FP, Uchikova EH, Mihaylov RD, Pencheva BG, Ivanova KI. High-sensitivity CRP levels in women with gestational hypertension, preeclampsia and in normotensive pregnant women and its correlations. Folia Medica. 2021;63(4):511-8.

Page NM, Woods RJ, Gardiner SM, Lomthaisong K, Gladwell RT, Butlin DJ, et al. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature. 2000;405(6788):797-800.

Tosun M, Celik H, Avci B, Yavuz E, Alper T, Malatyalioğlu E. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-α in normal pregnancies and in pregnancies complicated by preeclampsia. J Mat-Fet Neonat Med. 2010;23(8):880-6.

Ovayolu A, Turksoy VA, Ovayolu G, Ozek MA, Dogan I, Karaman E. Analyses of interleukin-6, presepsin and pentraxin-3 in the diagnosis and severity of late-onset preeclampsia. J Mat-Fetal Neonat Med. 2022;35(2):299-307.

Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS. Williams obstetrics. 24e. New York, NY, USA: Mcgraw-hill; 2014.

Chen H, Zhang J, Qin F, Chen X, Jiang X. Evaluation of the predictive value of high sensitivity C-reactive protein in pregnancy-induced hypertension syndrome. Experim Therap Med. 2018;16(2):619-22.

Joshi K, Acharya N, Acharya S, Joshi S, Joshi KS. Maternal Serum High-Sensitivity C-Reactive Protein (hsCRP) as a prognostic marker of fetomaternal outcome in hypertensive disorders of pregnancy: a novel study. Cureus. 2022;14(4).